The data showed that TolDex downregulated the expression levels of CD40, TNF-β, and IL-6; upregulated the expression level of TGF-β; and promoted Treg differentiation, suggesting that TolDex induces immune tolerance in RA. Here, CD40 is linked to rheumatoid arthritis.